GeneChem - Our Team - Martial Lacroix

GeneChem is a manager of focused venture capital funds. Since 1997, we have been involved in the launching of companies and in the management of their growth and liquidity events.

GeneChem has been part of investment syndicates which included a wide breadth of marquee international investors as well as smaller local players. The team has knowledge and expertise in various fields of science including biochemistry, chemistry, immunology, oncology, virology, bacteriology, analgesia, ophthalmology and human genetics.

We have invested at the very early stages of start-ups, where hands-on management is required, and also at the later stages such as mezzanine rounds and private placements in public entities. The team's experience is broad and deep-reaching within the biotech investment sector.

1 Westmount Square, Suite 800
Montreal, Quebec
H3Z 2P9
Canada

T 514-849-7696
F 514-849-5191
info@genechem.com

Martial Lacroix, PhD General Partner

Dr. Lacroix participated in the launch of the first GeneChem Fund in 1997. He has so far been on the Board of Directors of fifteen companies. Prior to becoming a venture capitalist, Dr. Lacroix, a co-founder of BioChem Pharma Inc. (acquired by Shire Pharmaceuticals Group in 2001), acted as a Director for Technology Transfer at BioChem Pharma. From 1986 to 1995, he held a number of positions with BioChem ImmunoSystems, Inc., including Director, Research and Development and Director, Quality Control. Between 1981 and 1986, Dr. Lacroix was a Professor in the Department of Virology at Institut Armand-Frappier. Dr. Lacroix received a B.Sc. and a M.Sc. in Biochemistry from Université de Montréal and a Ph.D. from the University of Toronto. Dr. Lacroix has authored 33 scientific publications and holds eight issued patents.

T 514-849-4430
F 514-849-5191
martial@genechem.com

© 2024 GeneChem. All rights reserved. Developed by Grafika Designs a Montreal Web Design company.